• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of Florida

Headquarters: Gainesville, FL, United States of America
Website: http://www.ufl.edu
Year Founded: 1906
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Nov 27, 2024
Discovery & Translation

Science Spotlight: Reducing immune rejection of stem cell-derived therapies

BioCentury’s roundup of translational innovation also includes a new target for arrhythmia and four papers with links to newcos
Read More
BioCentury | Nov 21, 2024
Deals

Still seeking smaller bolt-ons, Novartis takes out gene therapy play Kate

Deal for up to $1.1B with ‘significant upfront payment’ rewards syndicate including Westlake and Versant, gives pharma three preclinical programs for muscular dystrophies
Read More
BioCentury | May 17, 2024
Product Development

Vectorized antibodies are taking gene therapy beyond rare disease

ASGCT presentations showcase cancers, infectious diseases and chronic inflammatory conditions as potential applications of vectorized antibodies
Read More
BioCentury | May 4, 2024
Discovery & Translation

Science spotlight: Biotechs discover new checkpoint target, and more

BioCentury’s roundup of translational innovations
Read More
BioCentury | Dec 12, 2023
Distillery Therapeutics

A dual HDAC3 and HDAC8 degrader for breast cancer

Read More
BioCentury | Jun 16, 2023
Product Development

Patient organizations take on gene therapy’s redosing problem

If successful, a clinical trial funded by CureDuchenne, MDA and PPMD could have industry-wide consequences for gene therapy
Read More
BioCentury | Jun 8, 2023
Emerging Company Profile

KateTx: sending more AAV to muscle, less to liver

Kate’s platform for increasing the potency and decreasing the liver tox of AAVs has attracted Astellas as a partner
Read More
BioCentury | Feb 10, 2023
Discovery & Translation

Targeting PIKFYVE and SYF2 for ALS; plus new protein degraders and more

BioCentury's roundup of translational news
Read More
BioCentury | Jan 25, 2023
Emerging Company Profile

Fauna Bio: finding human drug targets using animal omics data

Bay Area biotech is taking a comparative genomics approach, starting with biobank data from the thirteen-lined ground squirrel
Read More
BioCentury | May 31, 2022
Product Development

WHO mobilizing monkeypox research strategy

Meeting to discuss designs for trials of therapies, vaccines
Read More
Items per page:
1 - 10 of 155